| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10509557 | Drug and Alcohol Dependence | 2013 | 8 Pages |
Abstract
Varenicline did not increase quit rates over placebo. Smoking cessation rates in methadone-maintained smokers are low and novel treatment strategies are required.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
M.D. Stein, C.M. Caviness, M.E. Kurth, D. Audet, J. Olson, B.J. Anderson,